Actualités Amundi ESTOXX50 Dly -1X Inv UCITS ETF A - BSX | Actions Euronext

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Three models of stenting system now available for palliative treatment of malignant common bile duct strictures NATICK, Mass., Oct. 6...

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley...

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel...

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the...

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amundi ESTOXX50 Dly -1X Inv UCITS ETF A (BSX)

Outils de qualité professionnelle, pour des investisseurs individuels.

BSX Actualités

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results

Boston Scientific Announces First Quarter Special Items

OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific

Boston Scientific Announces Additions to Clinical Sciences Organization

S&P Equity Research Has Positive View on New Medicare Medical Device Reimbursement Rules

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amundi ESTOXX50 Dly -1X Inv UCITS ETF A (BSX) Actualités

Amundi ESTOXX50 Dly -1X Inv UCITS ETF A (BSX)

Outils de qualité professionnelle, pour des investisseurs individuels.

BSX Actualités

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results

Boston Scientific Announces First Quarter Special Items

OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific

Boston Scientific Announces Additions to Clinical Sciences Organization

S&P Equity Research Has Positive View on New Medicare Medical Device Reimbursement Rules

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application